Valerie Morisset is CSO & VP at Eliem Therapeutics, Inc. (ELYM). They have made 7 open-market trades across 1 company since 2024, most recently 2024-07-22.
CIK 0001868517
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ELYM | 150,322 | $768K |
Shares reported on the most recent Form 4, priced at the 2024-07-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ELYM | SELL | 2024-07-19 | 2024-07-23 | $7.71 | $1.4M | -11.1% | -34.6% | N/A |
| ELYM | SELL | 2024-07-17 | 2024-07-19 | $6.93 | $557K | +7.0% | -21.0% | N/A |
| ELYM | SELL | 2024-07-16 | 2024-07-17 | $7.13 | $357K | +22.7% | -11.3% | N/A |
| ELYM | SELL | 2024-07-12 | 2024-07-16 | $7.03 | $948K | +25.4% | -11.7% | N/A |
| ELYM | SELL | 2024-07-09 | 2024-07-11 | $6.95 | $737K | +27.0% | -14.8% | N/A |
| ELYM | SELL | 2024-07-05 | 2024-07-09 | $7.06 | $174K | +12.0% | +1.2% | N/A |
| ELYM | SELL | 2024-07-03 | 2024-07-03 | $6.76 | $338K | +3.1% | +15.2% | -24.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.